You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 3, March 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  TECHNIQUE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (41)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fibrin Glue Achieves Hemostasis in Patients With Coagulation Disorders

Harry B. Kram, MD; Ragu C. Nathan, MD; Frederick J. Stafford, MD; Arthur W. Fleming, MD; William C. Shoemaker, MD

Arch Surg. 1989;124(3):385-387.


Abstract

• Fibrin glue (FG), made with highly concentrated human fibrinogen and clotting factors, was used to achieve parenchymal organ hemostasis in patients with disordered coagulation secondary to massive transfusion, chronic disease, and disseminated intravascular coagulation; it was effective in controlling liver hemorrhage in seven patients and in the performance of a splenorrhaphy in one other patient. The coagulation profile was grossly abnormal in all patients, and the mean ±SD intraoperative blood loss was 5.1 ±4.2 L; patients received 14± 10 U of blood perioperatively. The amount of FG required to achieve hemostasis varied directly with the extent of injury and intraoperative blood loss (r=.84), and all patients with a blood loss greater than 4 L required at least 25 mL of FG to stop bleeding. Two patients died postoperatively secondary to cardiac arrest and adult respiratory distress syndrome. Because FG does not depend on adequate platelet or clotting factor levels to be effective, it is especially useful in patients with parenchymal organ hemorrhage and disordered coagulation.

(Arch Surg 1989;124:385-387)



Author Affiliations

From the Department of Surgery, Martin Luther King, Jr-Charles R. Drew Medical Center, Los Angeles, and the UCLA School of Medicine.


Footnotes

Accepted for publication May 11, 1988.

Reprint requests to Department of Surgery, Martin Luther King Jr-Charles R. Drew Medical Center, 12021 S Wilmington Ave, Los Angeles, CA 90059 (Dr Kram).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Novel Uses of Fibrin Glue in Vascular Surgery
Mikucki and Greisler
PERSPECT VASC SURG ENDOVASC THER 1999;11:41-57.
ABSTRACT  

Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Current Options and Approaches for Blood Management in Orthopaedic Surgery*{{dagger}}
KEATING
JBJS 1998;80:750-62.
FULL TEXT  

Current Concepts Review - Blood Transfusion in Orthopaedic Operations
LEMOS and HEALY
JBJS 1996;78:1260-71.
FULL TEXT  

Transfusion Practices in Vascular Surgery
Spence
PERSPECT VASC SURG ENDOVASC THER 1993;6:14-43.
 

The Impact of Liver Reductions in Pediatric Liver Transplantation
Esquivel et al.
Arch Surg 1991;126:1278-1286.
ABSTRACT  

Fibrin Glue Inhibits Intra-abdominal Adhesion Formation
de Virgilio et al.
Arch Surg 1990;125:1378-1382.
ABSTRACT  

Closure of Blepharoplasty Incisions With Autologous Fibrin Glue
Mandel
Arch Ophthalmol 1990;108:842-844.
ABSTRACT  

Autologous Fibrin for Blepharoplasty Incisions
Mandel
JAMA 1989;262:3271-3272.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.